I don't understand the hate towards the FDA, I'm pretty sure they want to approve leronlimab as much as anyone. Cytodyn gave them a CD12 trial of apples and oranges. all they want is apples to apples. There is a very good reason for this, apples to apples comparisons show clearly what this drug is doing. Apples to oranges only adds EIND patient results and a placebo arm that did better than typical. We can't just rely on assuming patients got better because of Leronlimab, we have to prove it and it is only a trial design away from being accomplised.